Sales of the company’s copycat to J&J’s blockbuster reached $150 million in the first quarter, adding to a surge in revenue ...

Siren Biotechnology is trying to raise $5 million via the type of crowdfunding round that’s rarely used by young drugmakers.

A version of meloxicam designed to work faster has beat out a placebo in two late-stage studies focused on post-surgical ...

The Food and Drug Administration should look for ways to streamline regulations on new U.S. drug manufacturing facilities to ...

The company added to a recent flurry of pledges by pharmaceutical companies, promising $11 billion in new capital and ...

CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

Experts say market turmoil has made it harder for buyers and sellers to agree on price, which can be an especially imposing ...

Vor Bio, Korro Bio, Insitro and Rallybio revealed plans to lay off chunks of their respective workforces in the latest job ...

While updated study results confirmed the drug lowers a target protein, the therapy's effect on clinical outcomes was less ...

A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic ...

The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but ...